FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2550202055> ?p ?o ?g. }

• W2550202055 endingPage "246" @default.
• W2550202055 startingPage "238" @default.
• W2550202055 abstract "Primary factor VIII (FVIII) prophylaxis is the optimal treatment in children with severe haemophilia A. They are expected to benefit from extended half-life (T1/2 ) FVIII coverage by reduced infusion frequency while maintaining haemostatic efficacy.To determine immunogenicity, pharmacokinetics (PK), efficacy, safety and quality of life of prophylaxis with a polyethylene glycol (peg)-ylated FVIII (BAX 855) based on full-length recombinant FVIII (ADVATE) in paediatric previously treated patients (PTPs) with severe haemophilia A.PTPs <12 years without history of FVIII inhibitors received twice-weekly infusions of 50 ± 10 IU kg-1 BAX 855 for ≥50 exposure days. Prophylactic dose increases to ≤80 IU kg-1 were allowed under predefined conditions. PK was evaluated after single infusions of 60 ± 5 IU kg-1 .T1/2 and mean residence time were extended 1.3- to 1.5-fold compared to ADVATE (n = 31), depending on the analysis used. The point estimate for the mean annualized bleeding rate in 66 subjects receiving a median of 1.9 weekly infusions of 51.3 IU kg-1 of BAX 855 each was 3.04 (median 2.0); 1.10 (median 0) for joint and 1.16 (median 0) for spontaneous bleeds. Overall, 38% of subjects had zero bleeds. No bleeds were severe. Haemostatic efficacy was rated excellent or good for 90% of bleeds; 91% were treated with one or two infusions. In 8/14 subjects all target joints resolved. No subject developed FVIII inhibitors or persistent binding antibodies that affected safety or efficacy. No adverse reactions occurred.Twice-weekly prophylaxis with BAX 855 was safe and efficacious in paediatric PTPs with severe haemophilia A." @default.
• W2550202055 created "2016-11-30" @default.
• W2550202055 creator A5005934498 @default.
• W2550202055 creator A5010852837 @default.
• W2550202055 creator A5028498998 @default.
• W2550202055 creator A5042893306 @default.
• W2550202055 creator A5047028363 @default.
• W2550202055 creator A5059264212 @default.
• W2550202055 creator A5070985333 @default.
• W2550202055 creator A5074035144 @default.
• W2550202055 date "2016-11-27" @default.
• W2550202055 modified "2023-10-17" @default.
• W2550202055 title "Extended half-life pegylated, full-length recombinant factor VIII for prophylaxis in children with severe haemophilia A" @default.
• W2550202055 cites W1566919421 @default.
• W2550202055 cites W1623696825 @default.
• W2550202055 cites W1964148546 @default.
• W2550202055 cites W1966654557 @default.
• W2550202055 cites W1974873853 @default.
• W2550202055 cites W1974965024 @default.
• W2550202055 cites W1975668556 @default.
• W2550202055 cites W1993159801 @default.
• W2550202055 cites W1994744646 @default.
• W2550202055 cites W2000958165 @default.
• W2550202055 cites W2018471236 @default.
• W2550202055 cites W2019169178 @default.
• W2550202055 cites W2030561522 @default.
• W2550202055 cites W2050878694 @default.
• W2550202055 cites W2052198317 @default.
• W2550202055 cites W2059132948 @default.
• W2550202055 cites W2059740694 @default.
• W2550202055 cites W2072339301 @default.
• W2550202055 cites W2077857302 @default.
• W2550202055 cites W2084425785 @default.
• W2550202055 cites W2085306050 @default.
• W2550202055 cites W2090633688 @default.
• W2550202055 cites W2167801052 @default.
• W2550202055 cites W2168608087 @default.
• W2550202055 cites W2170050331 @default.
• W2550202055 cites W2323149989 @default.
• W2550202055 cites W4323282389 @default.
• W2550202055 doi "https://doi.org/10.1111/hae.13119" @default.
• W2550202055 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27891721" @default.
• W2550202055 hasPublicationYear "2016" @default.
• W2550202055 type Work @default.
• W2550202055 sameAs 2550202055 @default.
• W2550202055 citedByCount "65" @default.
• W2550202055 countsByYear W25502020552017 @default.
• W2550202055 countsByYear W25502020552018 @default.
• W2550202055 countsByYear W25502020552019 @default.
• W2550202055 countsByYear W25502020552020 @default.
• W2550202055 countsByYear W25502020552021 @default.
• W2550202055 countsByYear W25502020552022 @default.
• W2550202055 countsByYear W25502020552023 @default.
• W2550202055 crossrefType "journal-article" @default.
• W2550202055 hasAuthorship W2550202055A5005934498 @default.
• W2550202055 hasAuthorship W2550202055A5010852837 @default.
• W2550202055 hasAuthorship W2550202055A5028498998 @default.
• W2550202055 hasAuthorship W2550202055A5042893306 @default.
• W2550202055 hasAuthorship W2550202055A5047028363 @default.
• W2550202055 hasAuthorship W2550202055A5059264212 @default.
• W2550202055 hasAuthorship W2550202055A5070985333 @default.
• W2550202055 hasAuthorship W2550202055A5074035144 @default.
• W2550202055 hasBestOaLocation W25502020551 @default.
• W2550202055 hasConcept C126322002 @default.
• W2550202055 hasConcept C141071460 @default.
• W2550202055 hasConcept C159654299 @default.
• W2550202055 hasConcept C187212893 @default.
• W2550202055 hasConcept C197934379 @default.
• W2550202055 hasConcept C203014093 @default.
• W2550202055 hasConcept C203092338 @default.
• W2550202055 hasConcept C2777232031 @default.
• W2550202055 hasConcept C2778385053 @default.
• W2550202055 hasConcept C2780868878 @default.
• W2550202055 hasConcept C3020646304 @default.
• W2550202055 hasConcept C535046627 @default.
• W2550202055 hasConcept C71924100 @default.
• W2550202055 hasConceptScore W2550202055C126322002 @default.
• W2550202055 hasConceptScore W2550202055C141071460 @default.
• W2550202055 hasConceptScore W2550202055C159654299 @default.
• W2550202055 hasConceptScore W2550202055C187212893 @default.
• W2550202055 hasConceptScore W2550202055C197934379 @default.
• W2550202055 hasConceptScore W2550202055C203014093 @default.
• W2550202055 hasConceptScore W2550202055C203092338 @default.
• W2550202055 hasConceptScore W2550202055C2777232031 @default.
• W2550202055 hasConceptScore W2550202055C2778385053 @default.
• W2550202055 hasConceptScore W2550202055C2780868878 @default.
• W2550202055 hasConceptScore W2550202055C3020646304 @default.
• W2550202055 hasConceptScore W2550202055C535046627 @default.
• W2550202055 hasConceptScore W2550202055C71924100 @default.
• W2550202055 hasFunder F4320311257 @default.
• W2550202055 hasIssue "2" @default.
• W2550202055 hasLocation W25502020551 @default.
• W2550202055 hasLocation W25502020552 @default.
• W2550202055 hasOpenAccess W2550202055 @default.
• W2550202055 hasPrimaryLocation W25502020551 @default.
• W2550202055 hasRelatedWork W1853393307 @default.
• W2550202055 hasRelatedWork W1985140647 @default.
• W2550202055 hasRelatedWork W2030188337 @default.

• next